Perspective · 10 Sep 2026
Conference abstractPublished 17 Apr 2023
Development of a vaccine against leishmaniasis
University of Strathclyde, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the problem: Leishmaniasis is a serious neglected tropical disease and nearly 2 million people around the world are at risk of infection. Visceral leishmaniasis is fatal if untreated and most cases occur in Brazil, East Africa and in India. It remains one of the top parasitic diseases with outbreak and mortality potential. At present there is no clinical vaccine for leishmaniasis. Therefore, control is mainly managed by limiting transmission and treating active cases. The purpose of this study was to test a new vaccine candidate in a murine model of visceral leishmaniasis. Methodology & theoretical orientation: BALB/c mice were immunised with two doses of the vaccine candidate on days 0 and 21. The mice were infected alone with unvaccinated controls with 2 x 107 leishmania donovani amastigote parasites and parasites burdens determined 14 days later. Specific IgG1 and IgG2a antibody responses were monitored over the course of the study and antigen-specific responses were determined by completing a lymphocyte proliferation assay using spleen cells harvested at the end of the study [Figure 1]. Conclusion: Vaccination induced significant protection against infection but did not induce sterile immunity. Immunity was associated with a mixed specific Th1 and Th2 immune response.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Derya T. Ata”
